QA: Evolus Inc in us_pharma/2025

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001570562_2026_Evolus_Inc.pdf

Logs

Graph

Absolute values for 0001570562, Evolus Inc

  xvar xval
0 AssetsCurrent 142,917,000
1 IntangibleAssetsNetIncludingGoodwill 69,248,000
2 PropertyPlantAndEquipmentNet 5,371,000
3 remainder_Assets 8,332,000
4 LiabilitiesCurrent 75,305,000
5 LiabilitiesNoncurrent 6,371,000
6 remainder_Liabilities 167,298,000
7 CostOfGoodsAndServicesSold 144,930,351
8 SellingGeneralAndAdministrativeExpense 231,770,492
9 ResearchAndDevelopmentExpense 9,576,898
10 remainder_Expenses 24,099,736
11 remainder_Revenues 416,683,596
12 remainder_NetIncome 1,103,574
13 remainder_ComprehensiveNetIncome -476,789
  yvar yval
0 Assets 225,868,000
1 Liabilities 248,974,000
2 Expenses 410,377,477
3 Revenues 416,683,596
4 StockholdersEquity -23,106,000
5 NetIncome 7,409,693
6 ComprehensiveNetIncome 7,171,298
7 BaseVar 651,741,718
8 EconomicCapitalRatiobeforeLimitedLiability -0.182
9 EconomicCapitalRatio 1.41

Edgar->Model Mapping

Feature Distribution

Change over Time